Karyopharm Therapeutics Inc.

Nasdaq:KPTI

Pharmaceutical Preparations·NEWTON, MA

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	2/13/26	→
10-Q	Q3 2025	9/30/25	11/3/25	→
10-Q	Q2 2025	6/30/25	8/11/25	→
10-Q	Q1 2025	3/31/25	5/12/25	→
10-K	FY 2024	12/31/24	2/19/25	→
10-Q	Q3 2024	9/30/24	11/5/24	→
↓

Earnings Releases (8-K)

32 shown

Filed	Period
2/12/26	Q1 FY2026	→
1/12/26	Q4 FY2026	→
11/3/25	Q4 FY2025	→
10/8/25	Q3 FY2025	→
8/11/25	Q3 FY2025	→
5/12/25	Q2 FY2025	→
↓

News (8-K)

48 shown

Filed	Type	Description
3/3/26	Agreement	Entry into a Material Definitive Agreement	→
2/19/26	Vote	Submission of Matters to a Vote of Security Holders	→
10/14/25	Agreement	Entry into a Material Definitive Agreement	→
9/11/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
7/11/25	Reg FD	Regulation FD Disclosure	→
5/29/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
11/24/25	424B3	424B3	→
11/24/25	424B3	424B3	→
11/3/25	S-3	S-3	→
11/3/25	S-3	S-3	→
8/11/25	S-8	S-8	→
4/14/25	ARS	ARS	→
↓

Filing History(1000 filings)

TypeDateAccessionPeriodSize

Mar 3, 2026

0002045943-26-0000034

Mar 2, 2026

4.8 KB

Mar 3, 2026

0001837741-26-0000034

Mar 2, 2026

4.7 KB

Mar 3, 2026

0001865796-26-0000034

Mar 2, 2026

4.8 KB

Mar 3, 2026

0001825322-26-0000034

Mar 2, 2026

4.8 KB

Mar 3, 2026

0001804460-26-0000034

Mar 2, 2026

4.7 KB

Mar 3, 2026

0001942597-26-0000034

Mar 2, 2026

4.7 KB

8-K

Mar 3, 2026

0001503802-26-0000068-K

Feb 27, 2026

386.3 KB

8-K

Feb 19, 2026

0001193125-26-0593498-K

Feb 18, 2026

185.0 KB

Feb 19, 2026

0001193125-26-0593324

Feb 17, 2026

4.7 KB

SCHEDULE 13G/A

Feb 17, 2026

0001897612-26-000267

—

7.4 KB

10-K

Feb 13, 2026

0001193125-26-04939710-K

Dec 31, 2025

20.0 MB

SCHEDULE 13G/A

Feb 12, 2026

0000902664-26-000896

—

12.7 KB

8-K

Feb 12, 2026

0001193125-26-0476708-K

Feb 12, 2026

538.1 KB

SCHEDULE 13G

Feb 10, 2026

0001104659-26-012689

—

17.7 KB

Feb 9, 2026

0001193125-26-0427994

Feb 5, 2026

4.7 KB

Feb 4, 2026

0001193125-26-0375844

Feb 3, 2026

4.8 KB

Feb 3, 2026

0001193125-26-0356874

Jan 31, 2026

4.8 KB

Feb 3, 2026

0001193125-26-0356824

Jan 31, 2026

4.8 KB

Feb 3, 2026

0001193125-26-0356634

Jan 31, 2026

4.8 KB

Feb 3, 2026

0001193125-26-0356614

Jan 31, 2026

4.7 KB

Feb 3, 2026

0001193125-26-0356554

Jan 31, 2026

4.7 KB

SCHEDULE 13G/A

Jan 29, 2026

0001315863-26-000103

—

16.2 KB

Jan 29, 2026

0001193125-26-0295994

Jan 27, 2026

6.6 KB

Jan 22, 2026

0001193125-26-0194284

Jan 21, 2026

4.8 KB

8-K

Jan 12, 2026

0001193125-26-0097388-K

Jan 12, 2026

306.7 KB

25 filings shown

Filed	Form	Description
1/9/26	DEF 14A	DEF 14A	→
12/30/25	PRE 14A	PRE 14A	→
4/14/25	DEFA14A	DEFA14A	→
4/14/25	DEF 14A	DEF 14A	→
12/16/24	DEF 14A	DEF 14A	→
12/5/24	PRE 14A	PRE 14A	→
↓

Karyopharm Therapeutics Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1000 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/12/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/10/26	SCHEDULE 13G	SCHEDULE 13G	→
1/29/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/7/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓